SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Rare Earths & Materials, Corp. – ‘PRRN14A’ on 11/18/96 re: American Rare Earths & Materials, Corp.

As of:  Monday, 11/18/96   ·   Accession #:  1005444-96-100   ·   File #:  0-15260

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/18/96  American Rare Earths & Mate… Corp PRRN14A                1:10K  American Rare Earths & Mate… Corp Mountain Fi… Printing/FA

Revised Preliminary Non-Management Proxy Solicitation Material — Contested Solicitation or Other Situation   —   Schedule 14A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: PRRN14A     Revised Pages for Pre 14A for Biorelease Corp.         3     22K 

PRRN14A1st Page of 3TOCTopPreviousNextBottomJust 1st
 

[Enlarge/Download Table] BIORELEASE CORP (A DEVELOPMENT STAGE ENTERPIRSE) PROFORMA BALANCE SHEET SEPTEMBER 30, 1996 (Unaudited) Elimination Proforma Proforma Proforma ASSETS BCORP BTI TPI Adjustments Adjustments A/E # Results Cash ......................................... 156 0 23589 0 23745 Cash - held as collateral .................... 0 0 0 0 Investments in government securities ......... 0 0 0 0 Investments in government backed securities .. 0 0 0 0 Accounts receivable, trade ................... 0 192 0 (192) 5 0 Accounts receivable-affiliate ................ 3668534 0 5000 (3673534) 1,2 0 Inventories .................................. 0 27679 0 (27679) 5 0 Deferred income taxes ........................ 0 0 0 0 0 Other receivables ............................ 1015 0 0 0 1015 Prepaid expenses and other current assets .... 2311 0 0 0 2311 ------- ------- ------- ------- ------- ------- Total current assets .................... 3672016 27871 28589 (3673534) (27871) 27071 Equipment and leasehold improvements, net .... 27044 0 0 27044 Investments, net ............................. 4582 0 0 (4582) 8 0 Investments in subsidiaries .................. 0 3668534 (3668534) 1,6 0 Notes receivable - long term.................. 0 0 0 0 Intangible assets, net ....................... 0 36110 0 (36110) 5 0 Deverred income taxes - long term............. 0 0 0 0 0 Other noncurrent assets ...................... 398 300 0 0 (300) 5 398 Deferred underwriting fees for future offering 0 0 12500 12500 Deferred legal fees for future acquisition ... 14811 0 0 14811 ------- ------- ------- ------- ------- ------- Total assets ............................ 3718851 64281 41089 (5000) (3737397) 81824 ======= ======= ======= ======= ======= ======= LIABILITIES AND STOCKHOLDERS' EQUITY Accounts payable ............................. 28993 65453 3215 0 (65453) 5 32208 Accounts payable - affiliate ................. 5000 3668534 0 (5000) (3668534) 2,4 0 Accrued expenses ............................. 70779 25841 375 0 (25841) 5 71155 Notes payable - stockholders ................. 0 58100 80000 (58100) 5 80000 Income taxes payable ......................... 0 1549 0 (1549) 5 0 Deferred income taxes ........................ 0 0 0 0 0 Other current liabilities .................... 1748 4000 0 (4000) 5 1748 ------- ------- ------- ------- ------- ------- Total current liabilities ............... 106520 3823477 83590 (5000) (3823477) 185110 Notes payable - stockholders ................. 102689 14955 0 (25476) 5 102689 Deferred income tax........................... 0 16000 0 0 0 0 ------- ------- ------- ------- ------- ------- Total liabilities ....................... 209209 3848952 83590 (5000) (3848952) 267799 ------- ------- ------- ------- ------- ------- Stockholders' equity: Common stock.................................. 99217 5047 1 (1) (34835) 2,5,7,8,9 69428 Additional paid-in capital.................... 6989159 2129673 0 1 (2099885) 2,3,4,5,7,8,9 7018948 Development stage accumulated deficit.........(3524234)(5919391) (42501) 2246275 5,6,8 (7239851) Stock subscriptions receivable................ (50000) 0 (1) (50001) ------- ------- ------- ------- ------- ------- 3514142 (3784671) (42501) 0 111555 (201475) Less: Treasury stock........................ (4500) 0 0 (4500) ------- ------- ------- ------- ------- ------- Total stockholders' equity.................... 3509642 (3784671) (42501) 0 111555 (205975) ------- ------- ------- ------- ------- ------- Total liabilities and stockholders' equity.... 3718851 64281 41089 (5000) (3737397) 81824 ======= ======= ======= ======= ======= ======= -16-
PRRN14A2nd Page of 3TOC1stPreviousNextBottomJust 2nd
[Enlarge/Download Table] BIORELEASE CORP (A DEVELOPMENT STAGE ENTERPRISE) PROFORMA CONSOLIDATING STATEMENT OF OPERATIONS For the Three Months Ended September 30, 1996 (Unaudited) 3 MONTHS SEPT 1996 Elimination Proforma Proforma BCORP BTI TPI Adjustments Adjustments Results Revenues ..................................... 0 12691 0 12691 Cost of Goods Sold ........................... 0 0 0 0 ------- ------- ------- ------- ------- ------- Gross Profit 0 12691 0 0 0 12691 Operating expenses: Cell culture operations.................... 0 0 0 0 Research and development................... 0 0 0 0 Purchased technology....................... 0 0 0 0 General and administrative ................ (34405) (9912) (42501) (86818) Other...................................... 0 ------- ------- ------- ------- ------- ------- Loss from operations ......................... (34405) 2779 (42501) 0 0 (74127) Other income (costs) : Interest, net ............................. 0 (981) 0 (981) Accelerated lease cost..................... 0 0 0 0 Litigation costs........................... 0 0 0 0 Gain (Loss) on sale of assets.............. 0 0 0 0 Offering costs............................. 0 0 0 0 Option compensation........................ 0 0 0 0 Other income (settlements)................. 0 0 0 0 Other non operating costs.................. 0 0 0 0 Loss on disposition of invest- ment in subsidiaries .................... 0 0 0 (3671958) (3671958) Realized loss for decline in value of investment........................ 0 0 0 0 ------- ------- ------- ------- ------- ------- Loss before provision for (benefit) from) income taxes and cumulative effect of change in accounting principle.................... (34405) 1798 (42501) 0 (3671958) (3758776) (Provision) Credit for income taxes...................................... 0 0 0 0 ------- ------- ------- ------- ------- ------- Loss before cumulative effect of change in accounting principle............. (34405) 1798 (42501) 0 (3671958) (3758776) Comulative effect of change in accounting principle....................... 0 0 0 0 ------- ------- ------- ------- ------- ------- NET LOSS ..................................... (34405) 1798 (42501) 0 (3671958) (3758776) ======= ======= ======= ======= ======= ======= Weighted average shares ...................... 5117915 Loss per share ............................... (0.73215) -17-
PRRN14ALast Page of 3TOC1stPreviousNextBottomJust 3rd
[Download Table] BIORELEASE CORP CONSOLIDATED ELIMINATION AND PROFORMA ADJUSTING ENTRIES SEPTEMBER 30, 1996 ELIMINATION ENTRIES 1 ELIMINATE INTERCOMPANY RECEIVABLE/ PAYABLE IN CONSOLIDATION ACCOUNTS PAYABLE- AFFILIATE - BCORP 5000 ACCOUNTS RECEIVABLE - AFFILIATE - TPI 5000 2 ELIMINATE INVESTMENT IN SUBSIDIARIES COMMON STOCK - TPI 1 APIC - BCORP 1 ------- ------- 5001 5001 ======= ======= PROFORMA ADJUSTMENTS 3 TO RECLASSIFY BTI'S LIABILITY TO BCORP AS ADDITIONAL PAID IN CAPITAL ACCOUNTS PAYABLE- AFFILIATE - BTI 3668534 ADDITIONAL PAID IN CAPITAL - BTI 3668534 4 TO RECLASSIFY BCORP'S RECEIVABLE FROM BTI TO INVESTMENTS IN SUBSIDIARIES INVESTMENT IN SUBSIDIARIES - CORP 3668534 ACCOUNTS RECEIVABLE - AFFILIATE - B CORP 3668534 5 SPIN OUT BTI FROM CONSOLIDATED PROFORMA RESULTS ACCOUNTS PAYABLE- BTI 65453 ACCRUED EXPENSES - BTI 25841 NOTES PAYABLE STOCKHOLDERS -BTI 58100 INCOME TAXES PAYABLE - BTI 1549 OTHER CURRENT LIABILITIES - BTI 4000 NOTES PAYABLE - STOCKHOLDERS - BTI 25475 COMMON STOCK - BTI 5047 ADDITIONAL PAID IN CAPITAL - BTI 5798207 DEVELOPMENT STAGE ACCUMULATED DEFICIT -BTI 5919391 ACCOUNTS RECEIVABLE - BTI 192 INVENTORIES - BTI 27679 INTANGIBLE ASSETS - BTI 36110 OTHER NONCURRENT ASSETS - BTI 300 6 TO WRITE-OFF BCORP'S RECEIVABLE IN SUBSIDIARY BTI LOSS ON DISPOSITION OF INVESTMENT IN SUBSIDIARY - BCORP 3668534 INVESTMENTS IN SUBSIDIARIES - B CORP 3668534 7 PROFORMA ISSUANCE OF 1,650,000 BCORP STOCK TO SHAREHOLDERS OF TPI (BASED ON TPI RECEIVING 4 SHARES OF BIO FOR EACH SHARE OF TPI) (750BTI + 750 NEW BTI =1500sh x 2750 x4) ADDITIONAL PAID IN CAPITAL - BCORP 165000 COMMON STOCK - BCORP 165000 8 WRITE OFF BCORP'S INVESTMENT IN BTI LOSS ON DISPOSITION OF INVESTMENT IN SUBSIDIARY -BCORP 4582 INVESTMENTS, NET - BCORP 4582 9 REFLECT THE REVERSE SPLIT OF BCORP STOCK ON A ONE FOR FOUR BASIS COMMON STOCK - BCORP 194788 ADDITIONAL PAID IN CAPITAL - BCORP 194788 ISSUED BCORP SHARES 99217 LESS TREASURY STOCK (4500) BCORP SHARES ISSUED TO BTI 165000 ------ TOTAL PROFORMA SHARES 259717 SPLIT TO EQUAL 64929 ------ ADJUST 194788 ====== -------- -------- 10016576 10016576 ======== ======== -18-

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘PRRN14A’ Filing    Date First  Last      Other Filings
Filed on:11/18/96PRE 14A
9/30/961310QSB,  PRE 14A
 List all Filings 
Top
Filing Submission 0001005444-96-000100   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 1:56:05.1pm ET